Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MecMurphil appears to have been an Italian healthcare equipment company focused on devices used in nuclear medicine and radiopharmacy workflows rather than a drug-development biotech. Publicly available materials indicate it marketed products such as dose calibrators and hot cells for radiopharmaceutical handling, aimed at nuclear medicine laboratories and PET centers. Product names and videos reference systems including Murphil-Tc, Murphil-PET, and Murphil-Ga, suggesting shielding and processing equipment for different radiopharmaceutical applications. Corporate registry data now identifies the legal entity as "MECMURPHIL S.R.L. IN LIQUIDAZIONE," indicating the company is inactive and in liquidation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MecMurphil.